(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 87.55% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.98%, and it is also forecast to beat the US market's average forecast revenue growth rate of 58.59%.
Prenetics Global's revenue in 2025 is $66,320,000.On average, 2 Wall Street analysts forecast PRE's revenue for 2025 to be $1,358,524,881, with the lowest PRE revenue forecast at $1,318,172,656, and the highest PRE revenue forecast at $1,412,327,846. On average, 2 Wall Street analysts forecast PRE's revenue for 2026 to be $3,048,232,582, with the lowest PRE revenue forecast at $2,957,773,567, and the highest PRE revenue forecast at $3,168,983,556.
In 2027, PRE is forecast to generate $5,317,628,330 in revenue, with the lowest revenue forecast at $5,159,637,700 and the highest revenue forecast at $5,528,282,503.